Search results

  1. F

    Stanford Community Symposium 2018: Phair, Metabolic traps, Tryptophan trap

    Just found this by accident. Could someone send me a link to the original data/post. I was wondering if someone had checked the genetic data i.e. to see relationship between IDO2 mutation and incidence of ME/CFS. However, understanding even a small percentage of cases may help to explain the...
  2. F

    Stanford Community Symposium 2018: Phair, Metabolic traps, Tryptophan trap

    Only looked at this for a few minutes but what your saying seems reasonable. If IDO1/2 are not working then intracellular tryptophan will increase while intracellular kynurenine will decrease (Phair). It seems reasonable that intracellular Kynurenic acid will also decrease since it is formed...
  3. F

    Thyroid, autoimmune thyroiditis, Hashimoto's

    Thyroid stuff is really interesting. However, I haven't kept up with it. If you search on-line then you'll probably find stuff linking thyroid function to ME/CFS e.g. see below*. Ron Davis's son is pretty much low in everything. Ron Tompkins (OMF - Harvard) in a recent interview highlighted...
  4. F

    Trial By Error: Action For ME’s Employment Advice

    Andy, this reminds me of something I meant to share. If you look at Fluge and Mella's Rituximab study then I think you'll find that they used activity monitors (I think there are relatively cheap options out there - not sure which option Fluge & Mella used). Anyway; I think readers should...
  5. F

    Lobbying European Community for funding for ME/CFS Research

    Response from FMMM1: In order to try to understand EU funding for research into diseases such as Lyme I did some Googling; I didn't find much but I did find this answer to a Parliamentary question: "The remaining two years of Horizon 2020, and in particular its forthcoming calls for research and...
  6. F

    Lobbying European Community for funding for ME/CFS Research

    The European Union Commission has funded Lyme research (33.9 million Euros) but has not funded any ME/CFS research. The headline budget for the EU (science and technology) Horizon 2020 programme is approximately 80 billion euros [https://ec.europa.eu/programmes/horizon2020/en/what-horizon-2020]...
  7. F

    Lobbying European Community for funding for ME/CFS Research

    Thank you very much for the link. I too know little about the European Commission but yes it decides how to allocate funding. E.g. the European (Union) Commission has funded Lyme research [33.9 million euros (approximately same US dollars)] ME/CFS research has received zero funding. Currently...
  8. F

    Lobbying European Community for funding for ME/CFS Research

    Hi I've managed to get three (written) European Parliamentary questions asked on ME/CFS: Alex Mayer (S&D) Reference :E-006901/2017 Rory Palmer (S&D) Reference :E-004360/2018 Mairead McGuinness (PPE) Reference :E-006124/2018 If you Google the reference then you'll see the question. I'll update...
  9. F

    Erythrocyte Deformability As a Potential Biomarker for Chronic Fatigue Syndrome, Davis et al (2018)

    Study is titled: "Red blood cell deformability is diminished in patients with Chronic Fatigue Syndrome" and it's available here: https://content.iospress.com/articles/clinical-hemorheology-and-microcirculation/ch180469 I uploaded the wrong web address in my previous post Here's an extract from...
  10. F

    Erythrocyte Deformability As a Potential Biomarker for Chronic Fatigue Syndrome, Davis et al (2018)

    I've just received this "link to the complete version of the Red Blood Cell Deformability research paper" from OMF...
  11. F

    Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation, 2018, Unutmaz et al

    Thanks I think Ron Tompkins (spelling?) OMF pointed out that the expected cytokine storm in SEPSIS didn't occur/exist. I.e. cytokine levels weren't that high in SEPSIS - same goes for ME/CFS. Cort Johnson's article (see link above - in my original post) mentions this i.e. cytokines don't drive...
  12. F

    Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation, 2018, Unutmaz et al

    Thanks for your reply. I should have added a few caveats to my post; there's a lot of jumping between widely separated known pieces of this jigsaw. I don't know how to create a separate thread regarding lobbying; however, I' be grateful for advice/assistance.
  13. F

    Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation, 2018, Unutmaz et al

    Check out Fluge an Mella's (December 2016) paper "Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome" [https://insight.jci.org/articles/view/89376]. The authors state "According to this model, ME/CFS is caused by immune...
  14. F

    OMF: A Holiday message from Dr. Ron Davis, 2018

    I wonder if it's variability in the sample or variability in the instrument; I assume that it's variability in the instrument. E.g. test same patient multiple times and the results vary (e.g. you can't reliably extract the PBMCs/extract tryptophan from PBMCs) or test the same sample multiple...
  15. F

    Reduced glycolytic reserve in isolated natural killer cells from ME/CFS patients: A preliminary investigation, Nguyen et al, 2018

    Jumbled thoughts: Prof Don Staines presented data, at the Invest in ME Research International ME Conference 2018, indicating problems with calcium regulation. I assumed that they would/had published that data. I assume that the energy problems demonstrated in this paper are proposed to be a...
  16. F

    A Novel Nutriceutical Treatment of ME/CFS, 2017, Comhaire

    I came across a reference to Comhaire on a blog I like (Follow ME in Denmark) which was discussing impaired pyruvate dehydrogenase (PDH) functioning in ME/CFS i.e. Fluge & Mella's 2016 study. The blog also refers to a study on those born with a genetic impairment of PDH (Patel et al: The...
Back
Top Bottom